RSV N-nanorings fused to palivizumab-targeted neutralizing epitope as a nanoparticle RSV vaccine

Respiratory syncytial virus (RSV) is the leading cause of acute respiratory infections in children, yet no vaccine is available. The sole licensed preventive treatment against RSV is composed of a monoclonal neutralizing antibody (palivizumab), which targets a conformational epitope located on the f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nanomedicine
Main Authors: Hervé, Pierre-Louis, Deloizy, Charlotte, Descamps, Delphyne, Rameix-Welti, Marie-Anne, Fix, Jenna, McLellan, Jason S., Eléouët, Jean-François, Riffault, Sabine
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5698904/
https://ncbi.nlm.nih.gov/pubmed/27553073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2016.08.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados